SRI-41315 inhibits PTCs (premature termination codons) associated with cystic fibrosis in permanent and primary human bronchial epithelial cells by inducing a prolonged stoppage of the termination codon, restoring the expression and function of cystic fibrosis transmembrane conductance regulator (CFTR). In addition, SRI-41315 enhances aminoglycoside-mediated passaging, leading to a synergistic increase in CFTR activity.
Molecular Weight:
357.00
Purity:
>99.0%
CAS Number:
[1613509-49-1]
Formula:
C22H19N3O2
Target:
CFTR
* VAT and and shipping costs not included. Errors and price changes excepted